A new risk prediction model, the Revised REACH-B, demonstrated superior accuracy and reliability in predicting hepatocellular carcinoma, or liver cancer, risk compared to a previous model, offering improved risk stratification for patients.
A new risk prediction model, the Revised REACH-B, demonstrated superior accuracy and reliability in predicting hepatocellular carcinoma, or liver cancer, risk compared to a previous model, offering improved risk stratification for patients.
Designed by doctors. Powered by AI.
Owned by you.